Pharmaco - Press Releases

Date	Title	Company
28-Feb-2023	New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with late-onset Pompe disease	Sanofi
28-Feb-2023	Almirall opens the doors of its R&D centre to the biotech ZeClinics	Almirall
28-Feb-2023	UK faces £50bn economic hit due to spiralling medicines levy	Association of the British Pharmaceutical Industry (ABPI)
28-Feb-2023	Rare disease community call for their unified voice to be heard in the fight for equitable care	Sanofi
28-Feb-2023	Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars	Relief Therapeutics Holding SA
27-Feb-2023	Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion	BRAIN Biotech AG
27-Feb-2023	serYmun Yeast Announces Preclinical Safety and Efficacy Data for Their Yeast-Based Vaccine Against Porcine Parvovirus (PPV)	B3C newswire
27-Feb-2023	Online Pharmacies To Pioneer Future Of Healthcare, Claim Medical Experts	The Independent Pharmacy
27-Feb-2023	Biophytis initiates the regulatory process for an early access authorization in France from the French National Authority for Health (HAS) for the treatment with Sarconeos (BIO101) of severe forms of	Biophytis
27-Feb-2023	DEFENCE’S PIPELINE ADVANCES TO MULTIPLE PHASE I CLINICAL TRIALS	Defence Therapeutics Inc.
27-Feb-2023	BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting	BRAIN Biotech AG
24-Feb-2023	FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection	Sanofi
24-Feb-2023	PBD BIOTECH EXPANDS ITS PATENT PROTECTION FOR INCIPIENT TB TEST ACTIPHAGE®	PBD BIOTECH
24-Feb-2023	Terumo Blood and Cell Technologies presents first Quantum Flex data for multiple size bioreactors showing rapid T-Cell expansion to numbers equivalent to a therapeutic dose	Terumo Blood and Cell Technologies
24-Feb-2023	Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics	Pandemic Antiviral Discovery (PAD)
24-Feb-2023	ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva (cabotegravir, rilpivirine) is as effective as daily oral Biktarvy (BIC/FTC/TAF) for the treatment of HIV-1	ViiV Healthcare
24-Feb-2023	Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd	Olympus
23-Feb-2023	Abivax publishes a prospectus in the context of its capital increase	ABIVAX
23-Feb-2023	eXmoor pharma and vaccine developer Imophoron sign process development partnership	eXmoor pharma
23-Feb-2023	8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline	Worldwide Business Research